This summary was created by AI, based on 1 opinions in the last 12 months.
Based on the reviews from different experts, it appears that the company Cassava Sciences (SAVA-Q) is not recommended for investment. The general consensus among the experts is negative, with concerns about the company losing a lot of money. The company's financial performance and prospects appear to be a cause for caution. It is advisable for investors to carefully evaluate the risks associated with investing in this company before making any decisions.
Cassava Sciences is a American stock, trading under the symbol SAVA-Q on the NASDAQ (SAVA). It is usually referred to as NASDAQ:SAVA or SAVA-Q
In the last year, 1 stock analyst published opinions about SAVA-Q. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Cassava Sciences.
Cassava Sciences was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Cassava Sciences.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Cassava Sciences published on Stockchase.
On 2024-03-28, Cassava Sciences (SAVA-Q) stock closed at a price of $20.25.
It loses a lot of money. Can't recommend any of those companies.